Jun 12, 2019 - Amarin Corporation plc (NASDAQ:AMRN) Goldman Sachs 40th Annual Global Healthcare Conference Call June 12, 2019 4:20 P.M. ET Company Participants John Thero - President and Chief Executive Officer Conf
Jun 06, 2019 - Amarin Corporation plc (NASDAQ:AMRN) Jefferies 2019 Healthcare Conference Jun 06, 2019, 9:30 am ET Executives John Thero - President, Chief Executive Officer Analysts Michael Yee - Jefferies Presentat
May 30, 2019 - Amarin's (AMRN) label expansion application for hypertriglyceridemia drug, Vascepa, gets priority review from the FDA.
May 30, 2019 - If you are looking for interesting investment opportunities, then this diverse trio should be on your watch list.
May 29, 2019 - Gainers: Eltek (NASDAQ:ELTK) +373%. Valeritas Holdings (NASDAQ:VLRX) +40%. Soliton (NASDAQ:SOLY) +34%. Technical Communications Corporation (NASDAQ:TCCO) +30%. ReWalk Robotics (NASDAQ:RWLK) +28%. Nets
May 01, 2019 - Amarin Corporation PLC (NASDAQ:AMRN) Q1 2019 Earnings Conference Call May 1, 2019 7:30 AM ET Company Participants Elisabeth Schwartz – Senior Director-Investor Relations John Thero – President and Chi
May 01, 2019 - AMRN earnings call for the period ending March 31, 2019.
May 01, 2019 - Amarin (AMRN) surpasses estimates for earnings and sales in the first quarter of 2019.
Apr 24, 2019 - Amarin's (AMRN) cardiovascular drug, Vascepa to drive sales in the first quarter.
Mar 25, 2019 - Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately.